Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00790829|
Recruitment Status : Unknown
Verified August 2011 by Stony Brook University.
Recruitment status was: Recruiting
First Posted : November 14, 2008
Last Update Posted : August 12, 2011
|Condition or disease||Intervention/treatment||Phase|
|Postoperative Pain||Drug: transdermal nicotine patch||Not Applicable|
Study patients include nonsmokers aged 18-75 undergoing open abdominal wall surgery under general anesthesia. If the patient smokes, receives a regional anesthetic such as an epidural, or is pregnant, then he/she is excluded from the study. There are two randomized study groups. Group B receives a seven-milligram transdermal patch and Group A receives a placebo patch. Generic seven-milligram nicotine patches or identical placebo patches made from band-aids are glued to a 3x4 inch adhesive pad and placed on the individuals' right upper arm 1 hour before surgery. All patients are given a standardized anesthetic consisting of a narcotic infusion, propofol, a neuromuscular blocking agent, anesthetic gas agent, antinauseant medication and a nonsteroidal.
Patients receive postoperative analgesia for twenty four hours after surgery with a narcotic or an additional nonsteroidal medication. All patients receive intravenous controlled patient controlled analgesia (IVPCA) with morphine sulfate one milligram per ten minutes, forty milligram four hour limit. Patients also receive toradol fifteen milligrams for breakthrough pain. The patch is removed from participants twenty four hours post IVPCA initiation. The following items are assessed every four hours for twenty four hours after post anesthesia care unit discharge: a verbal rating of pain, total IVPCA morphine use, nausea occurrence, vomiting occurrence, and sedation score by the nurse.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||70 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Preemptive Use of Nicotine Patch for Postoperative Pain Relief in Open Abdominal Surgery|
|Study Start Date :||August 2007|
|Estimated Primary Completion Date :||August 2011|
|Estimated Study Completion Date :||September 2011|
Experimental: A, B
Group B received a seven-milligram transdermal patch and Group A received a placebo patch.
Drug: transdermal nicotine patch
Generic seven-milligram nicotine patches for 24hours, placebo patch for 24 hours
Other Name: Generic
- The efficacy of a low dose nicotine patch of seven milligrams placed before surgery and its effect on decreasing pain after surgery is the main purpose of the study. [ Time Frame: 24 hours ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00790829
|Contact: Ursula N Landman, DOemail@example.com|
|United States, New York|
|Stony Brook University Hospital||Recruiting|
|Stony Brook, New York, United States, 11794|
|Contact: Judy Matuk 631-632-9036 firstname.lastname@example.org|
|Contact: Ursula N Landman, DO 631-444-2975 email@example.com|
|Principal Investigator: Ursula N Landman, DO|
|Principal Investigator:||Ursula N Landman, DO||Stony Brook University Hospital|